Evidence map›Paper›PMID 26232442›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2015

A method for systematic discovery of adverse drug events from clinical notes.

Guan Wang, Kenneth Jung, Rainer Winnenburg, Nigam H Shah

Abstract readEvaluation StudyValidation Study
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Big data in IBD: a look into the future.Nature reviews. Gastroenterology & hepatology · 2019
    Review
  17. Article
  18. Leveraging Big Data to Transform Drug Discovery.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  19. Article
  20. Performing an Informatics Consult: Methods and Challenges.Journal of the American College of Radiology : JACR · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guan WangStanford University, Center for Biomedical Informatics, Stanford, California, USA guanw@stanford.edu.
Kenneth JungStanford University, Center for Biomedical Informatics, Stanford, California, USA guanw@stanford.edu.
Rainer WinnenburgStanford University, Center for Biomedical Informatics, Stanford, California, USA guanw@stanford.edu.
Nigam H ShahStanford University, Center for Biomedical Informatics, Stanford, California, USA guanw@stanford.edu.

Funding

STANFORD COMPOSITE(RMI)U54HG004028 · NHGRI · STANFORD UNIVERSITY · PI MUSEN, MARK A · 2005 to 2014
$36.2M
Methods for generalized ontology terms enrichment analysisR01LM011369 · NLM · STANFORD UNIVERSITY · PI SHAH, NIGAM H · 2013 to 2020
$5.0M
Mining health data for drug safety profilesR01GM101430 · NIGMS · STANFORD UNIVERSITY · PI SHAH, NIGAM H · 2013 to 2017
$2.9M
NHGRI NIH HHS U54 HG004028NIGMS NIH HHS R01 GM101430NLM NIH HHS R01 LM011369
6 · The paper itself

Abstract

objectiveAdverse drug events (ADEs) are undesired harmful effects resulting from use of a medication, and occur in 30% of hospitalized patients. The authors have developed a data-mining method for systematic, automated detection of ADEs from electronic medical records. MATERIALS AND

methodsThis method uses the text from 9.5 million clinical notes, along with prior knowledge of drug usages and known ADEs, as inputs. These inputs are further processed into statistics used by a discriminative classifier which outputs the probability that a given drug-disorder pair represents a valid ADE association. Putative ADEs identified by the classifier are further filtered for positive support in 2 independent, complementary data sources. The authors evaluate this method by assessing support for the predictions in other curated data sources, including a manually curated, time-indexed reference standard of label change events.

resultsThis method uses a classifier that achieves an area under the curve of 0.94 on a held out test set. The classifier is used on 2,362,950 possible drug-disorder pairs comprised of 1602 unique drugs and 1475 unique disorders for which we had data, resulting in 240 high-confidence, well-supported drug-AE associations. Eighty-seven of them (36%) are supported in at least one of the resources that have information that was not available to the classifier.

conclusionThis method demonstrates the feasibility of systematic post-marketing surveillance for ADEs using electronic medical records, a key component of the learning healthcare system.

Indexed as

Electronic Health RecordsData MiningDrug-Related Side Effects and Adverse ReactionsHumansMachine LearningProduct Surveillance, PostmarketingEMR miningmachine learningpharmacovigilancepost market drug safety surveillance

Identifiers

PMID26232442
PMCPMC4921953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.